Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 10,070
-430 (-4.10%)
Sep 18, 2026, 3:30 PM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 278.71 billion as of September 18, 2026. Its market cap has increased by 152.70% in one year.
Market Cap
278.71B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
166.89
Stock Price
10,070.00
ChartMarket Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 278.71B, an increase of 868.60%. That is a compound annual growth rate of 7.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 278.71B | 18.19% |
| Dec 30, 2025 | 235.81B | 137.66% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bukwang Pharmaceutical | 395.15B |
| Dong-A ST | 341.69B |
| EuBiologics | 309.09B |
| JW Holdings | 299.60B |
| Korea United Pharm | 256.22B |
| Humedix | 255.94B |
| Huons | 229.54B |
| Suheung | 228.29B |